Skip to content

    Evolent Health (EVH) stock price & financials

    View EVH earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance52.2% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $621.40M
    $646.54M
    $483.65M
    $444.33M
    $479.53M
    -22.8%
    $468.72M
    -27.5%
    $496.25M
    +2.6%
    $652.52M
    +46.9%
    Strengthening
    Operating Profit
    -$16.27M
    -$18.60M
    -$1.62M
    -$1.17M
    $886.0K
    -$408.23M
    -2095.3%
    -$10.60M
    -553.5%
    -$9.56M
    -716.5%
    Weakening
    Net Profit
    -$23.14M
    -$22.80M
    -$64.62M
    -$19.90M
    -$20.86M
    +9.8%
    -$429.13M
    -1782.0%
    -$26.63M
    +58.8%
    -$28.36M
    -42.6%
    Weakening
    EPS
    $-0.27
    $-0.27
    $-0.63
    $-0.44
    $-0.24
    +11.1%
    $-3.84
    -1322.2%
    $-0.24
    +61.9%
    $-0.25
    +43.2%
    Weakening
    Other Income
    Interest
    $6.01M
    $6.72M
    $10.38M
    $11.60M
    $16.48M
    +174.1%
    $19.01M
    +182.9%
    $16.87M
    +62.4%
    $16.86M
    +45.3%
    Strengthening
    Depreciation
    Profit before Tax
    -$23.76M
    -$23.92M
    -$63.15M
    -$20.72M
    -$19.96M
    +16.0%
    -$430.81M
    -1700.8%
    -$25.72M
    +59.3%
    -$25.65M
    -23.8%
    Weakening
    MarginsOPM
    -2.6%
    -2.9%
    -0.3%
    -0.3%
    0.2%
    -87.1%
    -2924.3%
    -2.1%
    -529.4%
    -1.5%
    -465.4%
    Weakening
    Tax
    2.6%
    4.7%
    -2.3%
    4.0%
    -4.5%
    -273.9%
    0.4%
    -91.7%
    -3.5%
    -51.9%
    -10.6%
    -366.1%
    Weakening
    ReturnsROIC
    1.7%
    1.7%
    4.7%
    1.5%
    1.5%
    -9.8%
    31.3%
    +1782.0%
    1.9%
    -58.8%
    2.1%
    +42.6%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$228.32M$101.01M$319.00M$266.28M$188.20M$192.82M$104.20M$151.86M$115.70M
    Short-Term Investments
    Total Current Assets$487.97M$228.80M$547.65M$523.96M$478.05M$683.67M$607.12M$506.37M$610.51M
    Net PP&E$73.63M$157.33M$144.04M$131.57M$136.90M$90.18M$79.28M$85.16M$84.63M
    Goodwill$768.12M$566.36M$349.03M$426.30M$722.77M$1.12B$1.14B$694.48M$694.43M
    Intangibles$335.04M$308.46M$264.99M$279.78M$442.78M$752.01M$680.16M$584.94M$554.43M
    Total Assets$1.72B$1.50B$1.37B$1.42B$1.82B$2.68B$2.54B$1.90B$1.97B
    LiabilitiesTotal Current Liabilities$269.36M$192.77M$403.29M$445.49M$433.44M$674.24M$715.50M$385.26M$492.83M
    Short-Term Debt$0$26.56M$0$0$0$171.47M$0
    Long-Term Debt$221.04M$293.67M$263.34M$215.68M$412.99M$597.05M$490.52M$970.54M$966.47M
    Long-Term Leases$0$68.86M$62.53M$57.72M$56.01M$38.01M$24.97M$3.82M$2.43M
    Total Liabilities$532.92M$568.97M$752.10M$725.83M$957.88M$1.43B$1.35B$1.48B$1.59B
    EquityCommon Stock & APIC$859.0K$908.0K$1.01M$1.15M$1.17M$1.18M$1.19M
    Retained Earnings$50.01M-$251.96M-$589.18M-$626.78M-$606.15M-$719.19M-$780.82M-$1.32B-$1.37B
    Total Equity$1.14B$929.05M$619.60M$693.63M$859.42M$1.07B$1.00B$415.19M$383.22M
    HighlightsNet Cash / (Debt)-$192.66M$29.10M$50.60M-$224.79M-$404.22M-$557.78M-$818.68M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$20.65M-$42.65M-$16.23M$38.75M-$11.55M$142.58M$18.77M$38.84M$54.32M
    Cash from Investing-$160.38M-$181.63M$261.07M-$15.79M-$259.12M-$415.54M-$62.93M-$233.0K$60.29M
    Cash from Financing$274.02M-$35.55M-$11.86M-$29.55M$131.54M$281.34M-$565.0K-$35.92M-$149.82M
    SummaryCapital Expenditure-$39.55M-$35.53M
    Free Cash Flow-$60.20M-$78.18M
    FCF Margin-9.6%-11.4%

    Ratios